A Strategic Alliance for the Orthopedic Market
On June 24, 2025, Medgen Life Science (Shenzhen) Co., Ltd. and Shanghai Sanyou Medical Devices Co., Ltd. (688085.SH) officially signed a national logistics service agreement for BoneSwift™ bone filling materials in Shenzhen, launching a nationwide strategic partnership for the orthopedic market. Sanyou Medical CEO Xu Nong and Medgen Life Science CEO Deng Siling attended the signing ceremony, announcing that the two companies will leverage complementary strengths to build a more efficient and optimized healthcare supply chain ecosystem, advancing high-quality development in the orthopedic medical industry.
Product Launch: Redefining Bone Surgery
While traditional bone repair materials remain constrained by cumbersome on-site mixing procedures, Medgen Life Science's independently developed BoneSwift™ — China's first hydroxyapatite pre-filled bone repair material — has officially received market approval. This innovative technology breaks through the limitations of conventional bone repair materials, delivering a leapfrog upgrade in both material performance and application methods, providing surgeons and patients with an entirely new treatment option.
Market Acceleration: Rapidly Building a Supply Chain and Logistics Network
Sanyou Medical (688085.SH), as a leading company specializing in orthopedic medical devices, has deep expertise in the orthopedic field and has become a trusted benchmark enterprise in the industry. This collaboration represents an extension of Sanyou Medical's professional service capabilities.
For Medgen Life Science, leveraging the advantages of Sanyou Medical's orthopedic logistics management system enables relatively rapid market entry, accelerating Medgen's supply chain development, improving product hospital access efficiency and logistics response speed, and ensuring timely fulfillment of clinical demand.
The Future Is Now: Advancing Market-Driven Collaboration
At this new crossroads in the market, leveraging and integrating complementary resources represents an open approach aligned with the era. This integration transcends traditional product-market models, offering greater market entry flexibility and open future development potential. Through resource integration, enabling quality bone repair solutions to reach patients and clinicians more quickly reflects the right corporate mindset.
About Medgen
Medgen Life Science (Shenzhen) Co., Ltd., formally established in 2017, is a high-tech biomedical enterprise focused on R&D and integrated manufacturing of novel regenerative repair materials in biomedical materials, regenerative engineering, and translational medicine. Supported by its two core technology platforms — hydroxyapatite regenerative product conversion and biomedical collagen crosslinking technology — the company's product portfolio spans orthopedics, sports medicine, dentistry, and medical aesthetics.
About Sanyou Medical
Shanghai Sanyou Medical Devices Co., Ltd., established in 2005, is a medical device company specializing in R&D, production, and sales of orthopedic implant consumables (Stock Code: 688085). The company's primary products include spinal implant consumables and trauma implant consumables. It is one of the few domestic enterprises in the spinal implant field with the capability for original innovation driven by clinical needs, and a scale and technology leader in the domestic spinal device segment with strong market competitiveness.